Share this article
Share this article
TORONTO, May 3, 2021 /PRNewswire/ -
Mountain Valley MD Holdings Inc. (the
Company or
MVMD ) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that the Company has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials with third-party cancer Contract Research Organizations (CROs) in triple-negative breast cancer, metastatic melanoma, and lung carcinoma.
Summary
MVMD files cancer patent for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad chemotherapeutic to immunotherapeutic cancer regimens.
The Company is proceeding with three separate pre-clinical trials with specialized third-party cancer CROs: (1) triple-negative breast cancer; (2) metastatic melanoma; and (3) Lewis Lung Carcinoma as a proxy for non-small cell lung carcinoma.
Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M D as Chief Medical Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Protara Therapeutics Announces Appointment of Martín Sebastian Olivo, M D as Chief Medical Officer
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
«Lockdown and all-related measures – the latter if adopted for prolonged and indefinite periods of time, well beyond the health emergency phase, so as to risk distorting the very essence of societies, and this is the case – are a crime against humanity as they constitute the crimes of imprisonment, torture and are acts causing great suffering to mental and physical health (section 7 of the Rome Statute)».
This is one of the most disruptive sentences of the explosive complaint signed by the Italian magistrate Angelo Giorgianni and sent yesterday, Wednesday 24 March, to the Prosecutor of the International Criminal Court (ICC) Ms Fatou Bensouda.